Overlooked by the international community, the already-dire situation in Kenya's overcrowded Dadaab refugee camps is worsening.

More >

In the remote Jebel Si area of North Darfur, a series of obstacles threaten to seriously hamper MSF's ability to provide medical assistance.

More >

MSF is a central player in treating lead poisoning in Zamfara state, and is responding to the acute phase of this emergency.

More >

MSF calls on the stakeholders of the Global Fund to convene an emergency donor conference and to open a new early funding window to ensure that the Fund is fully functional in 2012.

More >

This update details MSF's recent activities in South Sudan, the world's newest nation.

More >

Read MSF's submission to the US trade representative on the 2012 Special 301 review process, which affects accessibility of medicines and important diagnostic tools.

More >

Read Novartis's statements on its generic medicines court case, and learn why they're wrong.

More >

Learn more about why Novartis is taking India to court over the production of affordable generic medicines.

More >

Novartis is taking India to court to stop production of affordable generic medicines that millions of people depend on to stay alive.

More >

Learn how a free trade agreement between the European Union and India could restrict access to affordable medicines for millions of people with HIV/AIDS and other diseases and conditions.

More >

Pages